Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
Objectives:
To investigate the relationship between the administration of intravenous (IV) and oral
voriconazole (vori) and the occurrence of false positive (1,3) beta-d- glucan (BG) relative
to the standard assessment criteria used to diagnose invasive fungal infection in patients
with hematologic malignancies.